Article
Targeted proteomic quantitation of NRF2 signaling and predictive biomarkers in HNSCC
2023-03-17
Abstract excerpt
The NFE2L2/NRF2 oncogene and transcription factor drives a gene expression program that promotes cancer progression, metabolic reprogramming, immune evasion and chemoradiation resistance. Patient stratification by NRF2 activity may guide treatment decisions to improve outcome. Here, we developed a mass spectrometry (MS)-based targeted proteomics assay based on internal standard triggered parallel reaction monitori...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 58c488f6-c7be-5d83-8d7a-67e25333bbd0
- DOI
- 10.1101/2023.03.13.532474
